Nephros (NEPH) Change in Accured Expenses (2010 - 2026)
Nephros (NEPH) posted quarterly Change in Accured Expenses of -$791000.0 for Q1 2026, down 825.69% year-over-year from $109000.0 in Q1 2025, and down 315.53% quarter-over-quarter from $367000.0 in Q4 2025.
Nephros (NEPH) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Nephros' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$791000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 825.69% year-over-year to -$791000.0; the TTM figure through Mar 2026 stood at $124000.0 (down 52.85% YoY), while the FY2025 annual figure was $1.0 million, up 553.1% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$791000.0, down from $367000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $380000.0 in Q3 2025, with the low at -$791000.0 in Q1 2026.
- The 5-year median for Change in Accured Expenses is $88000.0 (2022), against an average of $21352.9.
- The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses surged 663.64% in 2025, then tumbled 825.69% in 2026.
- Nephros' Change in Accured Expenses stood at $24000.0 in 2022, then jumped by 237.5% to $81000.0 in 2023, then soared by 201.23% to $244000.0 in 2024, then soared by 50.41% to $367000.0 in 2025, then plunged by 315.53% to -$791000.0 in 2026.
- Business Quant data shows NEPH's Change in Accured Expenses at -$791000.0 in Q1 2026, $367000.0 in Q4 2025, and $380000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 55.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 50.56 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 50.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 29.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 311,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 311,000.00 |
| Jun 30, 2026 | 311,000.00 |
| Mar 31, 2026 | -791,000.00 |
| Mar 31, 2026 | -791,000.00 |
| Dec 31, 2025 | 367,000.00 |
| Dec 31, 2025 | 367,000.00 |
| Sep 30, 2025 | 380,000.00 |
| Sep 30, 2025 | 380,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 244,000.00 |
| Dec 31, 2024 | 244,000.00 |
| Sep 30, 2024 | -112,000.00 |
| Sep 30, 2024 | -112,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | -380,000.00 |
| Mar 31, 2024 | -380,000.00 |